Vivtex Enters Research Collaboration with Astellas Pharma

Maureen Deehan, CEO of Vivtex, commented: “We are delighted to enter this new collaboration with Astellas Pharma. Over the past few years, Vivtex has...

January 23, 2024 | Tuesday | News
ProteinLogic, Stellenbosch University Get $1.3M Grant for TB Blood Test Development

ProteinLogic extends ImmiPrint® Technology to address TB antimicrobial chemotherapy response monitoring. ProteinLogic ImmiPrint® diagnostic patt...

January 22, 2024 | Monday | News
Fujirebio and Agappe Ink CLIA Immunoassay Collaboration Agreement

In a significant move, Agappe and Fujirebio have revealed plans to launch these products in June 2024. The project has already achieved significant progres...

January 19, 2024 | Friday | News
Myriad Genetics Acquiring Intermountain Precision Genomics Assets

The acquisition is expected to close on February 1, 2024, subject to customary closing conditions. By bringing the Precise Tumor and Precise Liquid tests i...

January 19, 2024 | Friday | News
Basilea Acquires Preclinical Antibiotics Program from Spexis

Novel class of antibiotics Bactericidal activity demonstrated in vitro and in vivo against broad range of Gram-negative bacteria, including multidrug-re...

January 16, 2024 | Tuesday | News
Sequentify Granted Israel Innovation Authority Award for Disease Sequencing Panel

 Sequentify, a company specializing in DNA sequencing technology, has been granted funding by the Israel Innovation Authority (IIA). This grant, contr...

January 11, 2024 | Thursday | News
DNAnexus, Intelliseq Collaborate for Automated Genomic Variant Interpretation in Precision Health Data Cloud

-DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Intelliseq, a genome informatics company and innovative provider of next-generation s...

January 11, 2024 | Thursday | News
Vertex Granted Approval for First CRISPR Gene-Edited Therapy, CASGEVY™, in Saudi Arabia for Sickle Cell Disease and Beta Thalassemia Treatment

-Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced  that the Saudi Food and Drug Authority (SFDA) granted Marketing Authorization for CASGE...

January 10, 2024 | Wednesday | News
Element Biosciences Unleashes Next-Level Genomics Innovation: CEO Molly He Unveils AVITI Advancements at #JPM2024

The company is set to introduce multi-omics capabilities on the AVITI platform, along with enhancements to the first commercial Q50 kit and a host of workf...

January 09, 2024 | Tuesday | News
Curevo Vaccine Triumphs in Phase 2 Trial: Amezosvatein Beats Shingrix in Shingles Showdown!

- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust imm...

January 08, 2024 | Monday | News
Sail Biomedicines Secures Grants for RNA Medicines Against Malaria

-Sail Biomedicines, Inc. (“Sail” or the “Company”), a Flagship Pioneering company and leader in RNA-based programmable medicines, a...

January 04, 2024 | Thursday | News
Innovent, Xuanzhu Collaborate on Clinical Trial for Advanced Solid Tumors in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

December 28, 2023 | Thursday | News
Elpiscience, Astellas Partner on Bispecific Macrophage Engager

The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up to two...

December 28, 2023 | Thursday | News
BioNTech Hits Milestone with mRNA Vaccine Facility in Rwanda

Set-up of first BioNTainer as high-tech manufacturing solution for mRNA medicines is a critical step in establishing a resilient vaccine ecosystem in Afr...

December 19, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close